600594.SH
益佰制药
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 4.09
+9.95%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- -9.73x
- PEG TTM
- —
- Price / book
- 1.54x
- Price / sales
- 1.70x
- Price / cash flow
- 9.94x
Enterprise value
- Enterprise value
- CNY 3.1B
- EV / sales
- 1.81x
- EV / EBITDA
- -26.32x
- EV / EBIT
- -9.86x
- Market cap
- CNY 3.2B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026